Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours

HER-2/neu oncoprotein contains several major histocompatibility complex class I-restricted epitopes, which are recognised by cytotoxic T lymphocyte (CTL) on autologous tumours and therefore can be used in immune-based cancer therapies. Of these, the most extensively studied is HER-2(9(369)). In the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sotiropoulou, P A, Perez, S A, Iliopoulou, E G, Missitzis, I, Voelter, V, Echner, H, Baxevanis, C N, Papamichail, M
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2003
Teme:
Molecular and Cellular Pathology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376937/
https://ncbi.nlm.nih.gov/pubmed/12966425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601244
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items